ETF Holdings Breakdown of PACB

PACB institutional holdings

The adjusted close for PACB on 2025-11-12 was 1.74

The following institutional investment holdings of PACB have been identified

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2025-11-12	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	371,114	USD 645,738 -6.9%	1.74
2025-11-12	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	204,052 0.3%	USD 355,050 -6.6%	1.74
2025-11-12	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	204,052 0.3%	USD 355,050 -6.6%	1.74
Total =		779,218	USD 1,355,838

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with PACB

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Rating of “Hold” from Brokerages

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have been given a consensus recommendation of “Hold” by the eight analysts that are currently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The […] - 2025-08-11 05:18:54

XTX Topco Ltd Takes $576,000 Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

XTX Topco Ltd bought a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 488,237 shares of the biotechnology company’s stock, valued at approximately $576,000. XTX Topco Ltd owned […] - 2025-08-07 04:58:54

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Acquired by Wealthfront Advisers LLC

Wealthfront Advisers LLC raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 137.3% in the 1st quarter, HoldingsChannel.com reports. The fund owned 89,576 shares of the biotechnology company’s stock after buying an additional 51,825 shares during the quarter. Wealthfront Advisers LLC’s holdings in Pacific Biosciences of California were […] - 2025-07-23 05:53:08

Teacher Retirement System of Texas Invests $43,000 in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Teacher Retirement System of Texas acquired a new stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 36,528 shares of the biotechnology company’s stock, valued at approximately $43,000. Other institutional investors also recently added to […] - 2025-07-22 04:14:57

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Rating of “Hold” by Brokerages

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been given an average recommendation of “Hold” by the nine research firms that are presently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average […] - 2025-07-22 03:29:05

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. trimmed its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,565,331 shares of the biotechnology company’s stock after selling 613,170 […] - 2025-07-04 05:16:50

Barclays Has Lowered Expectations for Pacific Biosciences of California (NASDAQ:PACB) Stock Price

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price target cut by investment analysts at Barclays from $2.00 to $1.50 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the biotechnology company’s stock. Barclays‘s price objective points to a potential upside of 16.28% […] - 2025-06-27 02:42:44

Pacific Biosciences Of California To Present At Jefferies Conference; Webcast At 8:45 AM ET

(RTTNews) - Pacific Biosciences of California, Inc. (PACB) will present at Jefferies Healthcare Conference in . - 2025-06-05 08:45:26

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) have earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average […] - 2025-05-28 04:46:51

Cresset Asset Management LLC Sells 40,890 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Cresset Asset Management LLC cut its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 61.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,883 shares of the biotechnology company’s stock after selling 40,890 shares during […] - 2025-05-19 05:04:57

Raymond James Financial Inc. Invests $253,000 in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Raymond James Financial Inc. purchased a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 138,116 shares of the biotechnology company’s stock, valued at approximately $253,000. A number of other large investors also recently modified their holdings of the business. ARK Investment Management […] - 2025-05-12 04:22:50

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $2.45 Average PT from Brokerages

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average […] - 2025-05-06 02:30:47

Legal & General Group Plc Lowers Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Legal & General Group Plc lessened its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 234,635 shares of the biotechnology company’s stock after selling 16,736 shares […] - 2025-04-30 05:31:02

Geode Capital Management LLC Sells 64,981 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Geode Capital Management LLC lowered its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 1.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 6,262,925 shares of the biotechnology company’s stock after selling 64,981 shares during the quarter. Geode Capital Management LLC’s holdings in Pacific Biosciences of California […] - 2025-04-23 04:26:51

Cibc World Markets Corp Makes New Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)

Cibc World Markets Corp acquired a new stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,600 shares of the biotechnology company’s stock, valued at approximately $47,000. […] - 2025-03-28 06:18:45

Pacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.00 by Analysts at Scotiabank

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports. The brokerage currently has a “sector outperform” rating on the biotechnology company’s stock. Scotiabank’s price target points to a potential upside of 57.48% from the […] - 2025-03-27 04:46:50

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by New York State Common Retirement Fund

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – Free Report) by 299.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 84,725 shares of the biotechnology company’s stock after purchasing […] - 2025-03-06 08:56:56

Pacific Biosciences of California Sees Unusually High Options Volume (NASDAQ:PACB)

Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors acquired 31,944 call options on the stock. This represents an increase of approximately 477% compared to the typical volume of 5,533 call options. Wall Street Analyst Weigh In Several analysts have recently weighed […] - 2025-02-20 05:11:07

Back to Listing

Disclaimer